Overview

Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This is a controlled study to determine the effectiveness and safety of KL7016 in the treatment of adult patients with dry eye syndrome (DES).
Phase:
Phase 2
Details
Lead Sponsor:
KT&G Life Sciences Corp
Yungjin Pharm. Co., Ltd.